Poenaru Radu Cristian, Milanesi Elena, Niculae Andrei Marian, Dobre Anastasia-Maria, Vladut Catalina, Ciocîrlan Mihai, Balaban Daniel Vasile, Herlea Vlad, Dobre Maria, Hinescu Mihail Eugen
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest 050474, Romania.
Department of Radiobiology, Victor Babes National Institute of Pathology, Bucharest 050096, Romania.
World J Gastrointest Oncol. 2025 Jan 15;17(1):98409. doi: 10.4251/wjgo.v17.i1.98409.
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive lethal malignancy with limited options for treatment and a 5-year survival rate of 11% in the United States. As for other types of tumors, such as colorectal cancer, aberrant lipid synthesis and reprogrammed lipid metabolism have been suggested to be associated with PDAC development and progression.
To identify the possible involvement of lipid metabolism in PDAC by analyzing in tumoral and non-tumoral tissues the expression level of the most relevant genes involved in the long-chain fatty acid (FA) import into cell.
A gene expression analysis of , , , , , , , , and was performed by qRT-PCR in 24 tumoral PDAC tissues and 11 samples from non-tumoral pancreatic tissues obtained fine needle aspiration or surgical resection. The genes were considered significantly dysregulated between the groups when the p value was < 0.05 and the fold change (FC) was ≤ 0.5 and ≥ 2.
We found that three FA transporters and two long-chain acyl-CoA synthetases genes were significantly upregulated in the PDAC tissue compared to the non-tumoral tissue: (FC = 5.66; = 0.033), (FC = 2.68; = 0.040), (FC = 3.13; = 0.033), (FC = 4.10; < 0.001), and (FC = 2.67; = 0.012). We further investigated any possible association between the levels of the analyzed mRNAs and the specific characteristics of the tumors, including the anatomic location, the lymph node involvement, and the presence of metastasis. A significant difference in the expression of (FC = 3.28; = 0.040) was found comparing patients with and without lymph nodes involvement with an overexpression of this transcript in 17 patients presenting tumoral cells in the lymph nodes.
Despite the low number of patients analyzed, these preliminary results seem to be promising. Addressing lipid metabolism through a broad strategy could be a beneficial way to treat this malignancy. Future and studies on these genes may offer important insights into the mechanisms linking PDAC with the long-chain FA import pathway.
胰腺导管腺癌(PDAC)是一种侵袭性致命恶性肿瘤,治疗选择有限,在美国5年生存率为11%。与其他类型的肿瘤一样,如结直肠癌,异常的脂质合成和重新编程的脂质代谢被认为与PDAC的发生和发展有关。
通过分析肿瘤组织和非肿瘤组织中参与长链脂肪酸(FA)进入细胞的最相关基因的表达水平,确定脂质代谢在PDAC中的可能作用。
通过qRT-PCR对24例肿瘤性PDAC组织和11例通过细针穿刺或手术切除获得的非肿瘤性胰腺组织样本进行了、、、、、、、和的基因表达分析。当p值<0.05且倍数变化(FC)≤0.5且≥2时,认为两组间基因表达存在显著失调。
我们发现,与非肿瘤组织相比,三种FA转运蛋白和两种长链酰基辅酶A合成酶基因在PDAC组织中显著上调:(FC = 5.66;= 0.033),(FC = 2.68;= 0.040),(FC = 3.13;= 0.033),(FC = 4.10;< 0.001),以及(FC = 2.67;= 0.012)。我们进一步研究了分析的mRNA水平与肿瘤的特定特征之间的任何可能关联,包括解剖位置、淋巴结受累情况和转移的存在。在比较有和无淋巴结受累的患者时,发现(FC = 3.28;= 0.040)的表达存在显著差异,在17例淋巴结中有肿瘤细胞的患者中该转录本过表达。
尽管分析的患者数量较少,但这些初步结果似乎很有前景。通过广泛的策略解决脂质代谢问题可能是治疗这种恶性肿瘤的有益方法。未来对这些基因的和研究可能会为将PDAC与长链FA导入途径联系起来的机制提供重要见解。